Evelo Biosciences Probability of Future Pink Sheet Price Finishing Under 6.35
| EVLODelisted Stock | USD 8.23 2.68 24.56% |
Evelo |
Evelo Biosciences Target Price Odds to finish below 6.35
The tendency of Evelo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 6.35 or more in 90 days |
| 8.23 | 90 days | 6.35 | roughly 96.0 |
Based on a normal probability distribution, the odds of Evelo Biosciences to drop to $ 6.35 or more in 90 days from now is roughly 96.0 (This Evelo Biosciences probability density function shows the probability of Evelo Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Evelo Biosciences price to stay between $ 6.35 and its current price of $8.23 at the end of the 90-day period is under 4.
Given the investment horizon of 90 days Evelo Biosciences has a beta of -4.48 suggesting as returns on its benchmark rise, returns on holding Evelo Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Evelo Biosciences is expected to outperform its benchmark. In addition to that Evelo Biosciences has an alpha of 3.7937, implying that it can generate a 3.79 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Evelo Biosciences Price Density |
| Price |
Predictive Modules for Evelo Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evelo Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Evelo Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Evelo Biosciences is not an exception. The market had few large corrections towards the Evelo Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evelo Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evelo Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 3.79 | |
β | Beta against Dow Jones | -4.48 | |
σ | Overall volatility | 1.69 | |
Ir | Information ratio | 0.14 |
Evelo Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evelo Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evelo Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Evelo Biosciences is not yet fully synchronised with the market data | |
| Evelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (114.53 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evelo Biosciences currently holds about 92.01 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
Evelo Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evelo Pink Sheet often depends not only on the future outlook of the current and potential Evelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.4 M | |
| Cash And Short Term Investments | 47.9 M |
Evelo Biosciences Technical Analysis
Evelo Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Evelo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Evelo Biosciences. In general, you should focus on analyzing Evelo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Evelo Biosciences Predictive Forecast Models
Evelo Biosciences' time-series forecasting models is one of many Evelo Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Evelo Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Evelo Biosciences
Checking the ongoing alerts about Evelo Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Evelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Evelo Biosciences is not yet fully synchronised with the market data | |
| Evelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (114.53 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evelo Biosciences currently holds about 92.01 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |